Anti-MERS N [9H10]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (0)
- Inventor Info
Info
| Catalogue Number | 152663 |
| Applications | IF WB |
| Antigen/Gene or Protein Targets | MERS coronaviurs nucleocapsid protein |
| Reactivity | Virus |
| Relevance | A novel coronavirus (termed as severe acute respiratory syndrome coronavirus, SARS-CoV) was the cause of a viral outbreak which caused profound disturbances worldwide in 2003. Most recently, another novel coronavirus has achieved successful zoonotic transmission and been named as the Middle East respiratory syndrome coronavirus (MERS-CoV). As of 9 May 2014, a total of 536 people have been infected and the fatality rate is ~27%. As the Nucleocapsid protein (N) protein of coronavirus is an abundant virion protein and highly immunogenic, monoclonal antibody for MERS N will be useful for the detection of the virus especially if the monoclonal antibody can distinguish MERS-CoV from other human coronaviruses. |
| Host | Mouse |
| Immunogen | GST-MERS N fusion |
| Subclass | Inconclusive |
| Subclass Notes | Negative results for most recent batch |
| Myeloma Used | Sp2/0-Ag14 |
| Research Area | Virology |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference